Catalyst Event
Johnson & Johnson (JNJ) · Other
From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)
5/13/2026, 12:00:00 AM
Leerink Partners upgraded Johnson & Johnson stock to 'Outperform' from 'Market Perform' and raised its price target to $265 from $252, citing promising growth forecasts for new products Icotyde and Inlexzo; price impact estimated at 5% due to positive analyst sentiment forecasted.
Korean Translation
리링크 파트너스가 신제품 아이코타이드와 인렉조의 유망한 성장 전망을 근거로 존슨앤드존슨의 투자의견을 상향 조정하고 목표 주가를 인상함. 긍정적인 분석가 의견에 따라 약 5%의 주가 영향이 전망됨.
Related Recent Events
ON Semiconductor Corp (ON) · Other
Financial Analyst Day 2026 is scheduled for 2026-09-16; this event is estimated to have a ≥1% price impact, scheduled.
9/16/2026, 12:00:00 AM
Roblox Corp (RBLX) · Earnings Release
Roblox is scheduled to release its Q2 2026 earnings report on 2026-08-11. Low importance is estimated as date announcements have minimal impact, scheduled
8/11/2026, 12:00:00 AM
Kratos Defense & Security Solutions Inc (KTOS) · Earnings Release
Next quarterly earnings report for Q2 2026 is scheduled. Market impact is estimated at Medium as earnings releases typically result in 5-10% price movement.
8/6/2026, 12:00:00 AM
Curtiss-Wright Corp (CW) · Earnings Release
Q2 2026 earnings release expected.
8/5/2026, 12:00:00 AM
Occidental Petroleum Corp (OXY) · Earnings Release
Occidental Petroleum is expected to report its Q2 2026 earnings results around August 5, 2026, based on historical patterns expected.
8/5/2026, 12:00:00 AM
Masco Corporation (MAS) · Earnings Release
Masco's Q2 2026 earnings release is scheduled for July 30, 2026. Estimated 5% impact based on historical volatility during earnings periods expected.
7/30/2026, 12:00:00 AM